Salmonella Conjugates CVD 2000: Study of Responses to Vaccination With Trivalent Salmonella Conjugate Vaccine to Prevent Invasive Salmonella Disease
Condition: Risk Reduction Interventions: Biological: Trivalent Salmonella Conjugate Vaccine (TSCV) Full-Strength Formulation; Biological: Trivalent Salmonella Conjugate Vaccine (TSCV) Half-Strength Formulation; Biological: Trivalent Salmonella Conjugate Vaccine (TSCV) Dilutional Half-Strength Formulation; Other: Placebo Sponsor: University of Maryland, Baltimore Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials